TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bioplanum AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
30
|
365
|
474 |
| Financial expenses |
1
|
3
|
3 |
| Earnings before taxes |
-57
|
148
|
74 |
| EBITDA |
-56
|
150
|
76 |
| Total assets |
117
|
173
|
236 |
| Current assets |
104
|
160
|
223 |
| Current liabilities |
94
|
24
|
122 |
| Equity capital |
23
|
150
|
114 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
19.7%
|
86.7%
|
48.3% |
| Turnover per employee |
30
|
365
|
474 |
| Profit as a percentage of turnover |
-190.0%
|
40.5%
|
15.6% |
| Return on assets (ROA) |
-47.9%
|
87.3%
|
32.6% |
| Current ratio |
110.6%
|
666.7%
|
182.8% |
| Return on equity (ROE) |
-247.8%
|
98.7%
|
64.9% |
| Change turnover |
-323
|
-111
|
185 |
| Change turnover % |
-92%
|
-23%
|
64% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.